A critical breakthrough in cancer research is arising with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently inactivated in several types of malignancies, resulting https://mirrorbookmarks.com/story21849726/vhh-fragments-revive-p53-the-potential-approach-for-tumor-management